Provided is a pharmaceutical composition including an Abeliophyllum distichum extract as an active ingredient for treating androgen receptor-related diseases. The Abeliophyllum distichum extract according to the presently claimed subject matter or isoquercetin has an inhibitory activity against the androgen receptor and an excellent therapeutic effect on benign prostatic hyperlasia animal models, thus this finding can apply widely to the industry for relevant therapeutic agents for androgen receptor-related diseases such as benign prostatic hyperplasia, androgen-dependent hair loss, dysuria, and prostate cancer.

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

In one aspect, the present invention discloses a composition of forsythia suspensa component and an optional panax ginseng component that can be used safely, efficiently and consistently to achieve antiviral, antipyretic, anti-inflammatory and/or immunity boosting effects, including forsythin, forsythin derivatives, and the composition of forsythin and phillygenin for the prevention and treatment of diseases associated with human cytomegalovirus infection, such as simple human cytomegalovirus infection or for patients infected by human cytomegalovirus during prevention and treatment of cardiovascular and cerebrovascular diseases, tumors, bums or AIDS or during a process of organ transplantation or during the perinatal period. In another aspect, this application provides a process for preparing the composition of forsythia suspensa and panax ginseng components is simple, suitable for industrial production and easy to popularize.

In one aspect, the present invention discloses a composition of forsythia suspensa component and an optional panax ginseng component that can be used safely, efficiently and consistently to achieve antiviral, antipyretic, anti-inflammatory and/or immunity boosting effects, including forsythin, forsythin derivatives, and the composition of forsythin and phillygenin for the prevention and treatment of diseases associated with human cytomegalovirus infection, such as simple human cytomegalovirus infection or for patients infected by human cytomegalovirus during prevention and treatment of cardiovascular and cerebrovascular diseases, tumors, bums or AIDS or during a process of organ transplantation or during the perinatal period. In another aspect, this application provides a process for preparing the composition of forsythia suspensa and panax ginseng components is simple, suitable for industrial production and easy to popularize.

The present invention relates to compositions containing plant materials or extracts with inhibitory effect on a 5-HT.sub.3a and/or NK-1 receptor for preventing or treating idiopathic vomiting.

The present invention relates to compositions containing plant materials or extracts with inhibitory effect on a 5-HT.sub.3a and/or NK-1 receptor for preventing or treating idiopathic vomiting.

To provide a novel inflammasome inhibitor capable of inhibiting activation of inflammasome, the present inventors newly found that arctigenin reduces the amount of 1L-1β released and the amount of activated caspase-1 upon stimulation with ATP, palmitic acid, MSU and Poly(dA:dT) and thus has an effect of inhibiting inflammasome activation. The present invention provides an inhibitor of inflammasome activation that comprises arctigenin as an active ingredient.

To provide a novel inflammasome inhibitor capable of inhibiting activation of inflammasome, the present inventors newly found that arctigenin reduces the amount of 1L-1β released and the amount of activated caspase-1 upon stimulation with ATP, palmitic acid, MSU and Poly(dA:dT) and thus has an effect of inhibiting inflammasome activation. The present invention provides an inhibitor of inflammasome activation that comprises arctigenin as an active ingredient.